Viridian Therapeutics Ors Inc (VRDN)

Investing Cash Flow

-$231.16M

Quarterly · Period ending: · USD

VRDN logo

VRDN Investing Cash Flow

Latest reported-$231.16M
VRDN Quarterly Cash from Investing (-$25.00 → -$231.16M)
High-resolution chart · PNG

VRDN investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Viridian Therapeutics Ors Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-231,157,000
77,261,000
-339,420,000
126,077,000
75,718,000
100,062,000
-62,915,000
-84,667,000
61,976,000
-143,045,000
-169,711,000
48,041,000
40,713,000
-13,295,000
-180,603,000
42,651,000
13,963,000
8,863,000
-80,210,000
6,251,000
-11,205,000
10,872,000
-52,429,000
-53,000
0
2,001,000
7,000,000
11,021,000
13,025,000
-2,820,000
9,091,000
-6,014,000
-32,889,000
-95,000
-34,000
-63,000
-105,000
1,236,000
1,000,000
2,975,000
-4,120,000
-3,000
-23,000
-4,000
-24,000
-44,000
-261,384
-8,329
-4,268
-19
-2,642
-2,171
10,523
-25
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.